Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Monica Hecht"'
Publikováno v:
British Journal of Haematology. 138:446-458
Formation of osteolytic lesions is a key pathophysiological feature in multiple myeloma and results from the interaction of myeloma cells with the bone marrow microenvironment. Matrix metalloproteinases (MMPs) and plasmin may be involved in bone dest
Autor:
Claudia Fleissner, Maren Mieth, Monica Hecht, Jan Sterz, Christian Jakob, Orhan Sezer, Martin Kaiser, Holger Krebbel, R A Manz, I von Metzler, Lorenz Kleeberg, Ulrike Heider
Publikováno v:
Leukemia. 21:2025-2034
In multiple myeloma, the overexpression of receptor activator of nuclear factor kappa B (NF-kappaB) ligand (RANKL) leads to the induction of NF-kappaB and activator protein-1 (AP-1)-related osteoclast activation and enhanced bone resorption. The purp
Autor:
Orhan Sezer, Ulrike Heider, Ivana Zavrski, Christian Jakob, Christian Müller, Martin Kaiser, Monica Hecht, Claudia Fleissner, Carsten-Oliver Schulz
Publikováno v:
European journal of haematology. 77(3)
Objectives: Myeloma bone disease is a result of excessive osteoclast activation and impaired osteoblast function. Recent in vitro studies suggested that proteasome inhibitors might increase osteoblast function. Methods: We analyzed serum markers of o
Publikováno v:
Current medicinal chemistry. 12(26)
In human solid cancer, the lymph node status is the most important prognostic indicator for the clinical outcome of patients. Follow-up data has shown that about 80% of metastasis follows an orderly pattern of progression via the lymphatic network wh
Autor:
Monica Hecht, Ivana Zavrski, Claudia Fleissner, Martin Kaiser, Christian Jakob, Ulrike Heider, Orhan Sezer
Publikováno v:
European journal of cancer (Oxford, England : 1990). 42(11)
Bone disease, a hallmark of multiple myeloma occurs in the majority of the patients, is associated with bone pain, fractures, hypercalcemia and has major impacts on quality of life. Myeloma is characterized by a unique form of bone disease with osteo
Publikováno v:
Carcinogenesis. 26(12)
Neuroblastoma is the most frequent extracranial solid malignancy of childhood with a high mortality in advanced tumour stages. The hallmark of neuroblastoma is its clinical and biological heterogeneity. The molecular mechanisms leading to favourable
Publikováno v:
Biochemical and biophysical research communications. 330(3)
Neuroblastoma is the most frequent extracranial solid tumour of childhood. Despite multiple clinical efforts, clinical outcome has remained poor. Neuroblastoma is considered to be radiosensitive, but some clinical studies including the German trial N
Publikováno v:
Cancer research. 64(17)
Neuroblastoma is the most frequent solid childhood malignancy. Despite aggressive therapy, mortality is high due to rapid tumor progression to advanced stages. The molecules and mechanisms underlying poor prognosis are not well understood. Here, we r
Autor:
A. Elmaouhoub, Maria Papoutsi, Joerg Wilting, Giuliano Ramadori, C. S. von Kaisenberg, Bodo Christ, Monica Hecht, Bernhard Saile, Lothar Schweigerer, Jozsef Dudas, Stanislav I. Tomarev
Publikováno v:
Anatomy and Embryology. 208
Prox1 is a transcription factor with two highly conserved domains, a homeobox and a prospero domain. It has been shown that Prox1 knock-out mice die during early embryonic stages and display a rudimentary liver. We have studied the expression of Prox
Publikováno v:
Klinische Pädiatrie. 216